BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 221714)

  • 1. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
    Cooper AG; Codington JF; Miller DK; Brown MC
    J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
    Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
    J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
    Miller SC; Codington JF; Klein G
    J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
    Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycanin.
    Matsumoto I; Codington JF; Jahnke MR; Jeanloz RW; Osawa T
    Carbohydr Res; 1980 Apr; 80(1):179-89. PubMed ID: 7363275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
    Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
    Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
    Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
    Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.
    Springer GF; Desai PR
    Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY; Longenecker BM
    Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids.
    Codington JF; Klein G; Cooper AG; Lee N; Brown MC; Jeanloz RW
    J Natl Cancer Inst; 1978 Apr; 60(4):811-8. PubMed ID: 633390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum.
    Cooper AG; Codington JF; Brown MC
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1224-8. PubMed ID: 4524634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that the major cell suface glycoprotein of the TA3-Ha carcinoma contains the Vicia graminea receptor sites.
    Codington JF; Cooper AG; Brown MC; Jeanloz RW
    Biochemistry; 1975 Feb; 14(4):855-9. PubMed ID: 1115774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concanavalin A and other lectins in the study of tumor cell surface organization.
    Friberg S; Hammarström S
    Adv Exp Med Biol; 1975; 55():245-60. PubMed ID: 1098413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA.
    Shysh A; Eu SM; Noujaim AA; Suresh MR; Longenecker BM
    Int J Cancer; 1985 Jan; 35(1):113-9. PubMed ID: 3967949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor.
    Tenforde TS; Adesida PO; Kelly LS; Todd PW
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):277-82. PubMed ID: 6681773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural and histochemical differences in cell surface properties of strain-specific and nonstrain-specific TA3 adenocarcinoma cells.
    Miller SC; Hay ED; Codington JF
    J Cell Biol; 1977 Mar; 72(3):511-29. PubMed ID: 838766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
    Toda M; Hisano R; Yurugi H; Akita K; Maruyama K; Inoue M; Adachi T; Tsubata T; Nakada H
    Biochem J; 2009 Feb; 417(3):673-83. PubMed ID: 18925876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.